Merck and Pfizer Going To Court Over Korea FTC Fines; Lilly And GSK Watch From The Sidelines
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Merck, Sharp & Dohme Korea, Korea Otsuka Pharmaceuticals and Pfizer Korea are appealing the South Korea Fair Trade Commission decision to impose fines on the companies in January for unfair rebate provisions and other improper benefits to doctors and hospitalsYou may also be interested in...
Korean Ministry Plan To Order Penalty-based Price Cuts On Pharmaceuticals Faces Resistance From Global And Local Players
Korean Ministry Plan To Order Penalty-based Price Cuts On Pharmaceuticals Faces Resistance From Global And Local Players
Korean Government Fines Five Pharma Multinationals For Unfair Trade
Need a specific report? 1000+ reports available
Buy Reports